TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma

TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma

<i>Background</i>: There is no standard chemotherapy for refractory or relapsing malignant pleural mesothelioma (MPM). Our previous reports nevertheless indicated that a combination of an anthracycline (doxorubicin) and a lysine deacetylase inhibitor (valproic acid, VPA) synergize to ind...

Full description

Bibliographic Details
Main Authors: Bernard Staumont, Majeed Jamakhani, Chrisostome Costa, Fabian Vandermeers, Sathya Neelature Sriramareddy, Gaëlle Redouté, Céline Mascaux, Philippe Delvenne, Pascale Hubert, Roghaiyeh Safari, Luc Willems
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Cancers
Subjects:
mesothelioma
TGFα
chemoresistance
combination therapy
Online Access:https://www.mdpi.com/2072-6694/12/6/1484

Internet

https://www.mdpi.com/2072-6694/12/6/1484

Similar Items